Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Jun;163(2):199-205.
doi: 10.1007/s10549-017-4185-9. Epub 2017 Mar 8.

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis

Hope S Rugo  1 , Susan A Melin  2 , Jeff Voigt  3
Affiliations
Meta-Analysis

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis

Hope S Rugo et al. Breast Cancer Res Treat. 2017 Jun.

Abstract

Purpose: The risk of scalp metastases in patients using scalp cooling for preservation of hair during chemotherapy has been a concern but is poorly described.

Methods: A systematic review and meta-analysis of longitudinal studies was undertaken to evaluate the effect of scalp cooling versus no scalp cooling on the risk of scalp metastasis in patients treated for breast cancer with chemotherapy. Electronic databases, journal specific, and hand searches of articles identified were searched. Patients were matched based on disease, treatment, lack of metastatic disease, and sex.

Results: A total of 24 full-text articles were identified for review. Of these articles, ten quantified the incidence of scalp metastasis with scalp cooling over time. For scalp cooling, 1959 patients were evaluated over an estimated mean time frame of 43.1 months. For no scalp cooling, 1238 patients were evaluated over an estimated mean time frame of 87.4 months. The incidence rate of scalp metastasis in the scalp cooling group versus the no scalp cooling group was 0.61% (95% CI 0.32-1.1%) versus 0.41% (95% CI 0.13-0.94%); P = 0.43.

Conclusion: The incidence of scalp metastases was low regardless of scalp cooling. This analysis suggests that scalp cooling does not increase the incidence of scalp metastases.

Keywords: Breast cancer; Scalp cooling; Scalp metastasis.

PubMed Disclaimer

Conflict of interest statement

Hope S. Rugo, MD is a clinical investigator for Dignitana, but has not received compensation from Dignitana. Susan Melin, MD is a clinical investigator for Dignitana. Jeff Voigt is a reimbursement consultant for Dignitana.

Figures

Fig. 1
Fig. 1
PRISMA 2009 flow diagram
See this image and copyright information in PMC

References

    1. Howlander N, Noone AM, Krapcho M, et al (eds). SEER cancer statistics review, 1975–2012, National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2012/ based on November 2014 SEER data submission, posted to the SEER web site, April 2015
    1. American Cancer Society. Cancer facts & figures 2016. American Cancer Society, Atlanta. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2...
    1. National Comprehensive Cancer Network (NCCN) NCCN clinical practice guidelines in oncology. Breast Cancer. Version 1.2016. 2015 Nov 18; http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
    1. Henry NL, Somerfield MR, Abramson VG, et al. Role of patient and disease factors in adjuvant systemic therapy decision making for early-stage, operable breast cancer: American society of clinical oncology endorsement of cancer care Ontario guideline recommendations. J Clin Oncol. 2016;34:2303–2311. doi: 10.1200/JCO.2015.65.8609. - DOI - PubMed
    1. Choi EK, Kim I-R, Chang O, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psycho-Oncology. 2014;23:1103–1110. doi: 10.1002/pon.3531. - DOI - PubMed

MeSH terms

Substances